Chromium picolinate may improve blood sugar control
In this study, 71 people with type 2 diabetes and poorly controlled long-term average blood sugar levels took 600 mcg of chromium picolinate per day, or a placebo. After four months, the chromium picolinate group saw long-term average blood sugar (A1C) lowered by 1.9 while the placebo group declined 1.0. The chromium picolinate group also saw fasting blood sugar levels decline by 31 mg/dL compared to 14 for placebo, and after-meal blood sugar levels were 37 mg/dL lower for chromium picolinate compared to 11.5 for placebo.

Discussing the findings, doctors said they don’t know exactly how chromium picolinate improves blood sugar control but that research suggests chromium may play a role in insulin resistance and sensitivity by helping replace failing insulin receptor cells.

Reference: Journal of Trace Elements in Medicine and Biology; October, 2015, Vol. 32, 66-72.
Previous Next Back to Top
More Related Articles